Exercise-induced methylation of the Serhl2 promoter and implication for lipid metabolism in rat skeletal muscle.

Autor: Katayama M; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Nomura K; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden; Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan., Mudry JM; Section of Integrative Physiology, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Chibalin AV; Section of Integrative Physiology, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Krook A; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Zierath JR; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden; Section of Integrative Physiology, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. Electronic address: juleen.zierath@ki.se.

Publikováno v: Molecular metabolism [Mol Metab] 2024 Dec 08; Vol. 92, pp. 102081. Date of Electronic Publication: 2024 Dec 08.

Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trial.

Autor: Hepprich M; University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism, Basel, Switzerland., Mudry JM; University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism, Basel, Switzerland., Gregoriano C; Medical University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland., Jornayvaz FR; Division of Endocrinology, Diabetes, Nutrition and Therapeutic Patient Education, Geneva University Hospital, Genève, Switzerland., Carballo S; Sevice of General Internal Medicine, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland., Wojtusciszyn A; Service d'Endocrinologie Diabète et Métabolisme, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Bart PA; Service of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Chiche JD; Department of Intensive Care Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Fischli S; Department of Endocrinology, Luzerner Kantonsspital, Lucerne, Switzerland., Baumgartner T; Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland., Cavelti-Weder C; Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland., Braun DL; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland and Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Günthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland and Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Beuschlein F; Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland., Conen A; Division of Infectious Diseases and Infection Prevention, Kantonsspital Aarau, Aarau, Switzerland., West E; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland and Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Isenring E; Medical University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland., Zechmann S; University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism, Basel, Switzerland., Bucklar G; University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism, Basel, Switzerland., Aubry Y; University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism, Basel, Switzerland., Dey L; Hôpital du Jura, Site de Delémont, Delémont, Switzerland., Müller B; Medical University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland., Hunziker P; Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland., Schütz P; Medical University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland., Cattaneo M; Department of Clinical Research, University of Basel, Basel, Switzerland., Donath MY; University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism, Basel, Switzerland.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2022 Sep 17; Vol. 53, pp. 101649. Date of Electronic Publication: 2022 Sep 17 (Print Publication: 2022).

Spinster homolog 2/S1P signaling ameliorates macrophage inflammatory response to bacterial infections by balancing PGE2 production.

Autor: Fang, Chao¹ (AUTHOR), Ren, Pan² (AUTHOR), He, Yejun¹ (AUTHOR), Wang, Yitian¹ (AUTHOR), Yao, Shuting¹ (AUTHOR), Zhao, Congying² (AUTHOR), Li, Xueyong² (AUTHOR), Zhang, Xi³ (AUTHOR) xizhang@fmmu.edu.cn, Li, Jinqing⁴ (AUTHOR) lijinqing@xjtu.edu.cn, Li, Mingkai¹ (AUTHOR) mingkai@fmmu.edu.cn

Publikováno v: Cell Communication & Signaling. 9/30/2024, Vol. 22 Issue 1, p1-18. 18p.

miR-21, miR-221, miR-29 and miR-34 are distinguishable molecular features of a metabolically unhealthy phenotype in young adults.

Autor: Méndez-Mancilla, Alejandro^1,2 (AUTHOR), Turiján-Espinoza, Eneida^1,2 (AUTHOR), Vega-Cárdenas, Mariela² (AUTHOR), Hernández-Hernández, Gloria Estela¹ (AUTHOR), Uresti-Rivera, Edith Elena^1,2 (AUTHOR), Vargas-Morales, Juan M.^1,3 (AUTHOR), Portales-Pérez, Diana P.^1,2 (AUTHOR) dportale@uaslp.mx

Publikováno v: PLoS ONE. 4/25/2024, Vol. 19 Issue 4, p1-19. 19p.

Exercise in vivo marks human myotubes in vitro: Training-induced increase in lipid metabolism.

Autor: Lund J; Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway., Rustan AC; Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway., Løvsletten NG; Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway., Mudry JM; Integrative Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Langleite TM; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway., Feng YZ; Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway., Stensrud C; Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway., Brubak MG; Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway., Drevon CA; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway., Birkeland KI; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo, University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Kolnes KJ; Department of Physical Performance, Norwegian School of Sport Sciences, Oslo, Norway., Johansen EI; Department of Physical Performance, Norwegian School of Sport Sciences, Oslo, Norway., Tangen DS; Department of Physical Performance, Norwegian School of Sport Sciences, Oslo, Norway., Stadheim HK; Department of Physical Performance, Norwegian School of Sport Sciences, Oslo, Norway., Gulseth HL; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo, University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Krook A; Integrative Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Kase ET; Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway., Jensen J; Department of Physical Performance, Norwegian School of Sport Sciences, Oslo, Norway., Thoresen GH; Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway.; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Publikováno v: PloS one [PLoS One] 2017 Apr 12; Vol. 12 (4), pp. e0175441. Date of Electronic Publication: 2017 Apr 12 (Print Publication: 2017).